Accolade, Inc. (NASDAQ:ACCD) Receives $6.51 Average PT from Brokerages

Shares of Accolade, Inc. (NASDAQ:ACCD - Get Free Report) have earned an average rating of "Hold" from the fourteen research firms that are presently covering the stock, Marketbeat.com reports. Thirteen equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $6.51.

ACCD has been the topic of a number of research reports. Truist Financial downgraded shares of Accolade from a "strong-buy" rating to a "hold" rating in a report on Friday, January 10th. Stephens reiterated an "equal weight" rating and issued a $7.03 price target on shares of Accolade in a report on Wednesday, February 12th. Morgan Stanley reduced their price target on shares of Accolade from $6.00 to $5.00 and set an "equal weight" rating on the stock in a report on Tuesday, December 17th. Needham & Company LLC reiterated a "hold" rating on shares of Accolade in a report on Wednesday, January 8th. Finally, Canaccord Genuity Group reiterated a "hold" rating on shares of Accolade in a report on Wednesday, January 8th.

Institutional Trading of Accolade

Large investors have recently made changes to their positions in the business. Mission Creek Capital Partners Inc. purchased a new position in shares of Accolade during the 3rd quarter worth about $38,000. Pallas Capital Advisors LLC purchased a new position in shares of Accolade during the 4th quarter worth about $38,000. Laird Norton Wetherby Trust Company LLC purchased a new position in shares of Accolade during the 4th quarter worth about $38,000. Boothbay Fund Management LLC purchased a new position in shares of Accolade during the 4th quarter worth about $43,000. Finally, Wolverine Trading LLC purchased a new position in shares of Accolade during the 3rd quarter worth about $51,000. 84.99% of the stock is currently owned by institutional investors.

Remove Ads

Accolade Stock Performance

Shares of ACCD remained flat at $6.97 during trading hours on Thursday. 1,759,662 shares of the company were exchanged, compared to its average volume of 1,395,291. The company has a debt-to-equity ratio of 0.67, a quick ratio of 2.63 and a current ratio of 2.63. Accolade has a 52 week low of $3.08 and a 52 week high of $10.68. The company's 50-day simple moving average is $6.42 and its 200-day simple moving average is $4.67. The company has a market capitalization of $571.49 million, a P/E ratio of -3.10 and a beta of 2.18.

Accolade (NASDAQ:ACCD - Get Free Report) last released its earnings results on Friday, January 10th. The company reported ($0.30) earnings per share for the quarter, beating analysts' consensus estimates of ($0.31) by $0.01. Accolade had a negative net margin of 40.36% and a negative return on equity of 20.74%. On average, research analysts forecast that Accolade will post -1.2 EPS for the current year.

About Accolade

Accolade, Inc, together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians.